BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9673749)

  • 1. Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment?
    Henry A; Batey RG
    Aust N Z J Med; 1998 Jun; 28(3):345. PubMed ID: 9673749
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan.
    Yakoob J; Jafri W; Jafri N; Islam M; Abid S; Hamid S; AliShah H; Shaikh H
    World J Gastroenterol; 2005 Jun; 11(23):3562-5. PubMed ID: 15962375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with gastro-duodenal disease in patients undergoing upper GI endoscopy at the Korle-Bu Teaching Hospital, Accra, Ghana.
    Archampong TN; Asmah RH; Wiredu EK; Gyasi RK; Nkrumah KN
    Afr Health Sci; 2016 Jun; 16(2):611-9. PubMed ID: 27605979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
    Teixeira AV
    Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?
    Sugiyama T; Nishikawa K; Komatsu Y; Ishizuka J; Mizushima T; Kumagai A; Kato M; Saito N; Takeda H; Asaka M; Freston JW
    Dig Dis Sci; 2001 Feb; 46(2):307-10. PubMed ID: 11281179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of dynamic observation over patients with stomach and duodenum ulcer diseases after Helicobacter pylori eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2007; (4):19-24. PubMed ID: 18409486
    [No Abstract]   [Full Text] [Related]  

  • 9. Is Helicobacter pylori the primary cause of duodenal ulceration?
    Tovey FI; Hobsley M
    J Gastroenterol Hepatol; 1999 Nov; 14(11):1053-6. PubMed ID: 10574130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer].
    Ben Ammar A; Cheikh I; Ouerghi H; Chaabouni H; Kchaou M; Ben Mami N
    Tunis Med; 2002 Oct; 80(10):599-604. PubMed ID: 12632753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: Helicobacter pylori-negative duodenal ulcer disease.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2009 Oct; 30(8):791-815. PubMed ID: 19706147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of peptic ulcer perforation in Korea.
    Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
    World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in bleeding duodenal ulcer.
    Sfarti C; Stanciu C; Cojocariu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):704-9. PubMed ID: 20191819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
    Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis.
    Lo GH; Yu HC; Chan YC; Chen WC; Hsu PI; Lin CK; Lai KH
    Gastrointest Endosc; 2005 Sep; 62(3):350-6. PubMed ID: 16111950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Particularities of ulcer disease in children].
    Kalach N; Bontems P; Raymond J
    Arch Pediatr; 2010 Jun; 17(6):812-3. PubMed ID: 20654906
    [No Abstract]   [Full Text] [Related]  

  • 19. Multivariate analysis of risk factors for development of duodenal ulcer in Helicobacter pylori-infected patients.
    Regula J; Hennig E; Burzykowski T; Orlowska J; Przytulski K; Polkowski M; Dziurkowska-Marek A; Marek T; Nowak A; Butruk E; Ostrowski J
    Digestion; 2003; 67(1-2):25-31. PubMed ID: 12743437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated.
    Ciociola AA; McSorley DJ; Turner K; Sykes D; Palmer JB
    Am J Gastroenterol; 1999 Jul; 94(7):1834-40. PubMed ID: 10406244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.